Company intelligence / Profile preview

R and D Cell

Yongin-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

R&D Cell is a South Korean biotechnology company specializing in the development of advanced cell therapies, including autologous stem cells and natural killer (NK) cells. The company focuses on regenerative medicine and oncology, leveraging proprietary culture technologies to enhance the efficacy and safety of cell-based treatments. Their portfolio targets a range of conditions from degenerative joint diseases to various solid tumors. R&D Cell aims to provide personalized medical solutions through its specialized cell processing and storage services. The company is actively engaged in pre-clinical research to validate its cell therapy platforms for clinical applications.

Therapeutic areas: RheumatologyOncologyImmunology
Modalities: NK cell therapyStem cell therapyCell therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on R and D Cell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on R and D Cell.

Explore the full profile